UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000040977
Receipt No. R000046679
Scientific Title Study of changes in blood amino acid concentration by ingestion of test food(2)
Date of disclosure of the study information 2020/08/11
Last modified on 2021/01/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study of changes in blood amino acid concentration by ingestion of test food(2)
Acronym Study of changes in blood amino acid concentration by ingestion of test food(2)
Scientific Title Study of changes in blood amino acid concentration by ingestion of test food(2)
Scientific Title:Acronym Study of changes in blood amino acid concentration by ingestion of test food(2)
Region
Japan

Condition
Condition None
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Study of changes in blood amino acid concentration over time by ingestion of test food
Basic objectives2 Others
Basic objectives -Others Absorption kinetics after food ingestion
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Plasma amino acids concentration
Key secondary outcomes plasma glucose and insulin concentration

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 6
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Ingestion of study foodA substance (Once).
Interventions/Control_2 Ingestion of study foodB substance (Once).
Interventions/Control_3 Ingestion of study foodC substance (Once).
Interventions/Control_4 Ingestion of study foodD substance (Once).
Interventions/Control_5 Ingestion of study foodE substance (Once).
Interventions/Control_6 Ingestion of study foodF substance (Once).
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
40 years-old >
Gender Male
Key inclusion criteria 1) Japanese men aged 20-40 years.
2) Individuals who are healthy and are not suffered from a chronic malady.
3) Individuals whose written informed consent has been obtained.
4) Individuals who can visit an inspection facility and be inspected in designated days.
5) Individuals judged appropriate for the study by the principal.
6) Individuals who are not resistant to blood sampling.
Key exclusion criteria 1)Individuals using medical products.
2)Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease.
3)Individuals who contract or have a history of serious gastrointestinal disease.
4)Individuals who have an addiction to alcohol or a mental illness.
5)Individuals who used or applied a drug for treatment of disease in the past 1 month.
6)Individuals with probable seasonal allergy, such as pollinosis, during the test period.(In particular, Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense)
7)Individuals who have possibility of allergy symptoms onset by the test food and who cause severe allergic symptoms in foods and medicines.
8)Individuals cannnot drink milk,dairy products or soy milk.
9)Individuals with serious anemia.
10)Individuals with high blood glucose(fasting blood glucose over 126mg/dL).
11)Individuals who are a smoker.
12)Individuals whose life style will change during the test period.
13)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period.
14)Individuals who were hospitalized and received treatment in the past 6 months.
15)Individuals who participated in other clinical studies in the past 1 months or will participate in other clinical studies during the test period.
16)Individuals judged inappropriate for the study by the principal
Target sample size 12

Research contact person
Name of lead principal investigator
1st name Hiroko
Middle name
Last name Uchida
Organization MORINAGA & CO.,LTD
Division name Health Science and Research Center ,R&D institute
Zip code 230-8504
Address 2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama
TEL 045-571-6140
Email h-uchida-ji@morinaga.co.jp

Public contact
Name of contact person
1st name Mai
Middle name
Last name Wajiki
Organization MORINAGA & CO., LTD.
Division name Health Science and Research Center, R&D institute
Zip code 230-8504
Address 2-1-1, Shimodueyoshi, Tsurumi-ku, Yokohama
TEL 045-571-6140
Homepage URL
Email m-wajiki-ai@morinaga.co.jp

Sponsor
Institute MORINAGA & CO., LTD.
Institute
Department

Funding Source
Organization MORINAGA & CO., LTD.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Japan Conference of Clinical Research
Address 1-13-23 Minamiikebukuro, Toshima-ku, Tokyo
Tel 0368687022
Email None

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 08 Month 11 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 06 Month 04 Day
Date of IRB
2020 Year 06 Month 18 Day
Anticipated trial start date
2020 Year 06 Month 19 Day
Last follow-up date
2020 Year 08 Month 11 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 07 Month 02 Day
Last modified on
2021 Year 01 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046679

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.